Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

Escher, Claus M; Paracka, Lejla; Dressler, Dirk; Kollewe, Katja

Escher, Claus M; Paracka, Lejla; Dressler, Dirk; Kollewe, Katja.

Afiliación

Escher CM; Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
Paracka L; Department of Neurology, Movement Disorder Section, Hannover Medical School, Hannover, Germany.
Dressler D; Department of Neurology, Movement Disorder Section, Hannover Medical School, Hannover, Germany.
Kollewe K; Department of Neurology, Movement Disorder Section, Hannover Medical School, Carl-Neuberg Str. 1, D-30625 Hannover, Germany.

Ther Adv Neurol Disord ; 10(2): 127-135, 2017 Feb.

Article en En | MEDLINE | ID: mdl-28382110

Palabras clave

Botox®; botulinum neurotoxin; chronic daily headache; chronic migraine; onabotulinumtoxinA

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ther Adv Neurol Disord Año: 2017 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google